Mazumder Sonal, Pavurala Naresh, Manda Prashanth, Xu Xiaoming, Cruz Celia N, Krishnaiah Yellela S R
US Food & Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
US Food & Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
Int J Pharm. 2017 Jul 15;527(1-2):151-160. doi: 10.1016/j.ijpharm.2017.05.048. Epub 2017 May 23.
The present investigation was carried out to understand the impact of formulation and process variables on the quality of oral disintegrating films (ODF) using Quality by Design (QbD) approach. Lamotrigine (LMT) was used as a model drug. Formulation variable was plasticizer to film former ratio and process variables were drying temperature, air flow rate in the drying chamber, drying time and wet coat thickness of the film. A Definitive Screening Design of Experiments (DoE) was used to identify and classify the critical formulation and process variables impacting critical quality attributes (CQA). A total of 14 laboratory-scale DoE formulations were prepared and evaluated for mechanical properties (%elongation at break, yield stress, Young's modulus, folding endurance) and other CQA (dry thickness, disintegration time, dissolution rate, moisture content, moisture uptake, drug assay and drug content uniformity). The main factors affecting mechanical properties were plasticizer to film former ratio and drying temperature. Dissolution rate was found to be sensitive to air flow rate during drying and plasticizer to film former ratio. Data were analyzed for elucidating interactions between different variables, rank ordering the critical materials attributes (CMA) and critical process parameters (CPP), and for providing a predictive model for the process. Results suggested that plasticizer to film former ratio and process controls on drying are critical to manufacture LMT ODF with the desired CQA.
本研究旨在采用质量源于设计(QbD)方法,了解制剂和工艺变量对口腔崩解膜(ODF)质量的影响。以拉莫三嗪(LMT)作为模型药物。制剂变量为增塑剂与成膜材料的比例,工艺变量为干燥温度、干燥室内的空气流速、干燥时间和膜的湿膜厚度。采用确定性筛选实验设计(DoE)来识别和分类影响关键质量属性(CQA)的关键制剂和工艺变量。共制备了14种实验室规模的DoE制剂,并对其机械性能(断裂伸长率、屈服应力、杨氏模量、耐折度)和其他CQA(干厚度、崩解时间、溶出速率、水分含量、吸湿量、药物含量测定和药物含量均匀度)进行了评估。影响机械性能的主要因素是增塑剂与成膜材料的比例和干燥温度。发现溶出速率对干燥过程中的空气流速和增塑剂与成膜材料的比例敏感。对数据进行分析,以阐明不同变量之间的相互作用,对关键物料属性(CMA)和关键工艺参数(CPP)进行排序,并提供该工艺的预测模型。结果表明,增塑剂与成膜材料的比例以及干燥过程控制对于制备具有所需CQA的LMT ODF至关重要。